The association of long‐acting insulin analogue use versus neutral protamine Hagedorn insulin use and the risk of major adverse cardiovascular events among individuals with type 2 diabetes: A population‐based cohort study
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The association of
long‐acting
insulin analogue use versus neutral protamine Hagedorn insulin use and the risk of major adverse cardiovascular events among individuals with type 2 diabetes: A
population‐based
cohort study
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-06-21
DOI
10.1111/dom.14802
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Severe Hypoglycemia Risk With Long-Acting Insulin Analogs vs Neutral Protamine Hagedorn Insulin
- (2021) Marie C. Bradley et al. JAMA Internal Medicine
- Initiation of four basal insulins and subsequent treatment modification in people treated for type 2 diabetes in the United Kingdom: Changes over the period 2003–2018
- (2021) Vanessa C. Brunetti et al. DIABETIC MEDICINE
- Quality and completeness of diagnoses recorded in the new CPRD Aurum Database: evaluation of pulmonary embolism
- (2020) Susan S. Jick et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- CPRD Aurum database: Assessment of data quality and completeness of three important comorbidities
- (2020) Rebecca Persson et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum
- (2019) Achim Wolf et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Generalizability of glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United States
- (2019) Kristina S. Boye et al. DIABETES OBESITY & METABOLISM
- Myocardial Infarction—From Atherosclerosis to Thrombosis
- (2019) Jathushan Palasubramaniam et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2018) Aidin Rawshani et al. NEW ENGLAND JOURNAL OF MEDICINE
- 7. Diabetes Technology: Standards of Medical Care in Diabetes—2019
- (2018) DIABETES CARE
- Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2018) Melanie J. Davies et al. DIABETOLOGIA
- Data Resource Profile: Hospital Episode Statistics Admitted Patient Care (HES APC)
- (2017) Annie Herbert et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Insulin analogues in type 1 diabetes mellitus: getting better all the time
- (2017) Chantal Mathieu et al. Nature Reviews Endocrinology
- Validity of estimated prevalence of decreased kidney function and renal replacement therapy from primary care electronic health records compared with national survey and registry data in the United Kingdom
- (2017) Masao Iwagami et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes
- (2017) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- New Long-Acting Basal Insulins: Does Benefit Outweigh Cost?
- (2016) Eberhard Standl et al. DIABETES CARE
- Clinical workload in UK primary care: a retrospective analysis of 100 million consultations in England, 2007–14
- (2016) F D Richard Hobbs et al. LANCET
- All-Cause and Cause-Specific Mortality among Users of Basal Insulins NPH, Detemir, and Glargine
- (2016) Arto Y. Strandberg et al. PLoS One
- Hypoglycemia and Risk of Cardiovascular Disease and All-Cause Mortality in Insulin-Treated People With Type 1 and Type 2 Diabetes: A Cohort Study
- (2014) Kamlesh Khunti et al. DIABETES CARE
- Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial
- (2013) et al. EUROPEAN HEART JOURNAL
- Lower incidence of macrovascular complications in patients on insulin glargine versus those on basal human insulins: A population-based cohort study in Italy
- (2013) S. Cammarota et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study
- (2013) E. Herrett et al. BMJ-British Medical Journal
- Bias in Observational Studies of Prevalent Users: Lessons for Comparative Effectiveness Research From a Meta-Analysis of Statins
- (2012) Goodarz Danaei et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- SNOMED CT Implementation
- (2012) A. Randorff Højen et al. METHODS OF INFORMATION IN MEDICINE
- Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Multiple imputation using chained equations: Issues and guidance for practice
- (2010) Ian R. White et al. STATISTICS IN MEDICINE
- Comparison of Incidence of Acute Myocardial Infarction in Patients With Type 2 Diabetes Mellitus Following Initiation of Neutral Protamine Hagedorn Insulin Versus Insulin Glargine
- (2009) George G. Rhoads et al. AMERICAN JOURNAL OF CARDIOLOGY
- Constructing Inverse Probability Weights for Marginal Structural Models
- (2008) S. R. Cole et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Long-acting insulin analogues versus NPH human insulin in type 2 diabetes
- (2008) Matteo Monami et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials
- (2008) L. A. Bazzano et al. DIABETIC MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started